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ABSTRACT: Anthracenenitrile oxide undergoes 1,3-dipolar
cycloaddition reactions with 1-substituted-4-(prop-2-yn-1-
yloxy)benzene affording the expected isoxazoles in good
yields and as single regioisomers. N−O Bond cleavage and
boron complexation afforded the corresponding boron
complexes, derivatized with either a triple bond for click-
chemistry applications or an oxime group for nitrile oxide 1,3-
dipolar cycloaddition. The optical properties of these
compounds show potential for employment as fluorescent tags in imaging techniques. The activity-based protein profiling
assays showed good reactivity for the synthesized probes even with short peptide chains (epoxomicin). Scope and limitations
are discussed in the light of the obtained results.
■ INTRODUCTION
1,3-Dipolar cycloadditions can be undoubtedly considered a
pillar of the synthesis of isoxazoles. The versatility of this
strategy was recently applied to synthesize structures designed
for imaging. Albeit the number of works devoted to this topic
is increasing, the applications of the probes constructed via this
pathway remain quite low so far.1 In a recent conceptual work,
we successfully employed 1,3-dipolar cycloaddition of stable
aromatic nitrile oxides to afford novel fluorescent compounds.
The reported strategy is the cornerstone to furnish boron-
substituted complexes suitable for biochemical applications;
the nitrile oxide-based protocol is cleaner and selective with
dipolarophiles and can be a useful alternative to the use of
azides. Indeed, once properly derivatized, it can find proper use
in the activity-based protein profiling (ABPP).2
ABPP is one of the most powerful tools to gain insight into
complex biological systems, e.g., the activity of enzymes in
complex proteasomes.3 The aim of ABPP resides in the
visualization of the active forms of the enzymes using chemical
probes directed to the active site of a target protein, resulting
in the selective labeling of the sole catalytically active form of
the enzyme.4
Structurally, chemical probes consist of three different parts:
recognition tag, variable length linker, and warhead (ligation
handles) containing the functional groups to link the probe
with the target substrate with highly specific interactions that
make the probe selective for a well-defined biological structure
(Scheme 1). The ligation strategy we wish to exploit is based
on 1,3-dipolar cycloaddition for the two-step activity-based
labeling of endogenously expressed enzymes in complex
biological samples.5
The investigated probes aimed to be applied in a labeling
procedure that enabled us to label active proteasome β-
subunits selectively in cellular extracts and in living cells.
In our previous work, we detailed the synthetic strategy and
the fluorescence study of compound 5 that structurally follows
the aforementioned paradigms. The compound is synthesized
starting from a 1,3-dipolar cycloaddition reaction between 1-
iodo-4-(prop-2-yn-1-yloxy)benzene (2), affording the 5-
substituted isoxazole 3 in very good yields as a single
regioisomer. The outcome of the transformation nicely follows
the predictions based on the frontier orbital theory.2 Cleavage
of the N−O bond and BF3 complexation furnish the
corresponding fluorescent boron complex of type 5 (Scheme
1). The molecule bears an anthryl substituent (Ar = 9-anthryl)
on the tag and a triple CC bond on the warhead end
terminus (R = −CCH) of the probe, suitable for click-
chemistry applications and late-stage functionalization.
Here, we present a strategy to prepare chemical probes that
maintain the same tag structure, while bearing variable ligation
handles prone to orthogonal functionalization with a
proteasome inhibitor peptide. In compound 5, the triple
bond requires the use of a substrate bearing a dipole (typically
an azido-derivative) to connect the two sides of the chemical
reporter (Scheme 2). The newly designed compound 6 bears
Received: March 11, 2019
Accepted: April 17, 2019
Published: April 29, 2019
Article
http://pubs.acs.org/journal/acsodfCite This: ACS Omega 2019, 4, 7766−7774
© 2019 American Chemical Society 7766 DOI: 10.1021/acsomega.9b00672
ACS Omega 2019, 4, 7766−7774
This is an open access article published under an ACS AuthorChoice License, which permits


























































an oxime moiety on the warhead part that is suitable to be
oxidized to nitrile oxide. Hence, the probe is another 1,3-dipole
that can be attached to a double (or triple) bond located on a
target substrate. One of the great advantages of the use of
nitrile oxides is the fact that the cycloaddition reactions are
cleaner than those in the presence of azides; these latter ones
require metals (copper ions, typically) that are detrimental for
the cellular environment.
Scheme 1. From Nitrile Oxides 1 to 5-Substituted Isoxazoles 3, N−O Bond Cleavage and Boron Complexation: Synthetic
Route to Fluorescent Probes of Type 5 and 6
Scheme 2. Probe Structures: Dipolarophile and Dipole Precursor Ligation Handle Structures




ACS Omega 2019, 4, 7766−7774
7767
The two chemical probes 5 and 6 will be compared from the
photophysical point of view and tested by coupling them with
differently functionalized epoxomicin derivatives. Ultimately,
competitive ABPP assays will be performed to verify the
maintenance of proteasome inhibitor properties and possible
differences in terms of selectivity.
■ RESULTS AND DISCUSSION
The commercially available 4-hydroxybenzaldehyde 7 was
derivatized with freshly distilled propargyl chloride in the
presence of a base under reflux in acetonitrile (Scheme 3). The
ethynyl derivative 8 is a known compound6 and was
transformed into the corresponding oxime by treatment with
hydroxylamine in a hydro-alcoholic solution, to afford
compound 10.7 The oxime dipolarophile was allowed to
react with an equimolecular amount of anthracenenitrile oxide
9 in anhydrous dichloromethane (DCM) at room temperature
for 48 h. After purification, the 5-substituted isoxazole 11 was
obtained in 66% yield.8 In the 1H NMR spectrum (dimethyl
sulfoxide, DMSO), the diagnostic signal of the H4 proton of
the isoxazole ring was detected at δ 7.03 ppm. The inclusion of
the dipolarophile moiety into the cycloadduct was also
confirmed by the presence of the methyleneoxy group at δ
5.53 ppm (singlet) and by the highly deshielded oxime OH
signal at δ 11.06 ppm.
The selective N−O bond cleavage9 in the isoxazole moieties
was performed using Mo(CO)6 to give the 4-[(4-amino-4-
(anthracen-9-yl)-2-oxobut-3-en-1-yl)oxy] benzaldehyde oxime
12 as a reddish solid in 68% yield. As previously reported,2 the
signals detected in the 1H NMR spectrum denote the existence
of an intramolecular hydrogen bond between the amino group
and the carbonyl functionality obtained from the N−O bond
cleavage. As a consequence, one of the NH2 protons is found
at δ 8.47 ppm whereas the other is strongly deshielded at δ
10.25 ppm. The latter is the direct evidence of the 6-membered
cyclic array kept together by the hydrogen bond.
The enaminoketone 12 was used as ligand for boron
complexation,10 achieved by adding BF3·Et2O in an anhydrous
DCM solution, in the presence of Et3N (Scheme 3). Boron
complex 6 was obtained as a yellow solid in 40% yield. In the
1H NMR spectrum, a single NH proton signal is detected at δ
7.62 ppm, as a consequence of the newly formed bond
between the nitrogen and the boron.
To verify the reactivity of the fluorescent probe 6 as 1,3-
dipole, we oxidized the oxime group with ([bis-
(trifluoroacetoxy)iodo]benzene) (PIFA) in the presence of
an excess of norbornene (Scheme 4).11 Norbornene, an
excellent trap for nitrile oxides,12 is able to attach the in situ
formed nitrile oxide from compound 6, affording the
corresponding 1,3-dipolar cycloadduct 13 in 81% yield, and
the reaction does not require any metal promoter such as
copper that is normally used with azides. Hence, the reaction is
cleaner, and after simple chromatographic purification,
compound 13 was fully characterized; the presence in the 1H
NMR spectrum of the signals corresponding to the isoxazoline
protons at δ 3.64 and 4.55 ppm clearly indicates the successful
coupling between the nitrile oxide moiety and the CC
double bond of the norbornene.
To evaluate the potential use of the new boron complex 6 as
a chemical probe in biological studies, we performed some
UV−vis and fluorescence studies in solvents of different
polarities, comparing the results with those previously obtained
for compound 5.2
Figure 1 shows the UV−vis spectra of compounds 5 and 6 in
DCM as solvent. The oxime derivative 6 showed an absorption
band at 384 nm (ε = 5.00 × 103 M−1 cm−1) with a shoulder at
238 nm and vibrational peaks. Analogously, the BF2 complex 5
shows an absorption band at 387 nm (ε = 8.20 × 103 M−1
cm−1) along with more structured vibrational peaks compared
with compound 6. The change in functional groups on the
phenyl ring does not drastically shift the absorption peak in the
Scheme 4. 1,3-Dipolar Cycloaddition Reaction of Probe 6 with Norbornene
Figure 1. UV−vis spectra of compounds 5 (A) and 6 (B) in DCM (2
× 10−5 M solutions).
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near-UV region. It however results in a broadening of the
absorption band around 250 nm that merges with the blue-
shifted shoulder.
The fluorescence emission spectra of 5 and 6 are shown in
Figure 2. The fluorescence maxima for both the compounds
appear at 490 nm, indicating a Stokes’ shift of ca. 5630 cm−1
for the two complexes. The emission spectra are structureless
for both compounds and present a single intense peak. The
complete loss of the vibrational features, along with the
considerable Stokes’ shift, could be indicative of a structural
rearrangement occurring at the excited state. This feature is
less pronounced in more rigid fluorescent boron derivatives.13
Indeed, the first excited-state optimized structure of compound
6 at the SMD(DCM)-TD-CAM-B3LYP/6-31G(d,p)//TD-
B3LYP/6-31G(d,p) level of theory differs from the Franck−
Condon one, due to the torsion along the bond connecting the
boracycle to the anthryl moiety.14 The associated dihedral
angle varies from ca. 66 to 41°. Such a structural change is an
indication of the nature of the electronic transition associated
to fluorescence. The excited state populates an antibonding
orbital that spans from the anthryl moiety to the boracycle with
an electron coming from the anthracene (see Figure 3).
Consequently, the two connected cycles involved in the
transition bend to increase the conjugation in the molecule.
In DCM, compound 6 is characterized by fluorescence
quantum yield ΦF = 0.07 whereas compound 5 exhibits ΦF =
0.602 (both values were determined relative to the fluorescent
intensity of a boron-substituted reference compound; for
further details refer to the Supporting Information SI).10 The
low quantum yields of compound 6 even in DCM could be the
indication of intermolecular quenching of fluorescence. It is
known that a protic environment can influence the excited-
state nature of fluorophores.15 The source of this interaction
could be the hydroxylamino derivative in compound 6, absent
in compound 5. To test our hypothesis, we optimized
compound 6 at the SMD(DCM)-TD-CAM-B3LYP/6-31G-
(d,p)//TD-B3LYP/6-31G(d,p) level, in the presence of a
water molecule, as a prototypical protic compound. In this
case, the excited-state changes in nature and a charge-transfer
electron transfer from the phenoxy moiety to the anthryl one
quenches the fluorescence. Hence, we can conclude that the
interaction of 6 with a protic solvent or with its hydroxylamino
moiety can be the culprit for the low quantum yields of 6 (see
Figure 3).
The solvent effect on the absorption and fluorescence
properties of the new boron complex 6 was examined (spectra
reported in the SI), and Table 1 reports the ΦF values
obtained. The absorption (λmax) values of 6 are not affected by
solvent polarity, suggesting that the dipole moments of the
molecule in the ground and excited states are almost the
same.16 On the other hand, the maximum of fluorescence
emission (λem) values showed a blue shift of about 40 nm in
polar solvents with respect to the value in DCM. This
determined a Stokes’ shift reduction at just about ca. 3820
cm−1. These results show the same trend as that observed for
compound 5.2 Significantly, the ΦF values dramatically
diminish upon polarity changes as well as viscosity; remarkable
drops in quantum yields are observed in MeOH (0.01) and in
ethylene glycol (0.02). The same happens in the 1:1 DMSO/
H2O mixture with ΦF value = 0.01. This could suggest some
drawbacks when the compound is used in a biological
environment.17
On the basis of novel and previous observations and with the
aim to employ compounds 5 and 6 in ABPP assays, we
performed a series of coupling experiments with suitable
epoxomicin derivatives. Azido-substituted epoxomicin 14, a
proteasome inhibitor peptide, was coupled with the ethynyl-
probe 5 under standard click-reaction conditions (Scheme
5).3,4 The expected product 15 was isolated and purified by
column chromatography. Retaining of water in the final
compound required a prolonged drying step. After the drying
process, the product was obtained in 55% yield and the mass
spectrum (MS) reported a mass value of 1023.30 m/z
corresponding to the molecular weight of 15 (1006.94 m/z)
plus OH (MW + OH). This discrepancy in the MS spectra
values can be tentatively attributed to the harsh purification
protocol followed (even with standard methods) that
presumably left on the polar peptide chain residues of the
basic treatment. We cannot exclude the epoxide ring opening
to give a diol or even the stabilization of the hydrate forms of
the carbonyl group adjacent to the oxirane ring.
On the other hand, norbornene-substituted epoxomicin 16
was allowed to react with oxime 6 under oxidative conditions
(using phenyliodine diacetate (PIDA) as an oxidant in
dimethylformamide (DMF) at room temperature). The in
situ-generated nitrile oxide of 6 was added exo-selectively19 to
the CC bond of the norbornene moiety to afford the
corresponding 1,3-dipolar cycloadduct 17 (Scheme 6),
presumably as a mixture of regioisomers that would not affect
the biological behavior. Due to the known reactivity of nitrile
oxides with nucleophilic centers and the nature of the
dipolarophile, the purification step was quite problematic and
several steps of chromatographic purification were needed.
Nevertheless, the final cycloadduct was obtained in 45% yield
Figure 2. Fluorescence spectra of compounds 5 (A) and 6 (B) in
DCM (blue line, absorption; black line, emission).
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and the MS spectrum confirmed the structure as drawn in
Scheme 6 with MW = 1199.30 (theor. 1199.15) m/z.
The coupling products 15 and 17 were then tested in
competitive ABPP assays (sodium dodecyl sulfate polyacryla-
mide gel electrophoresis, SDS-PAGE) to check the main-
tenance of the proteasome inhibitor properties of epoxomi-
cin20 and the display of fluorescence properties. The
competitive SDS-PAGE assay was performed with some
other marked proteasome inhibitors (details in the SI).
The analysis was done on Raji cell lysate (1 μL), containing
both immuno and constitutive proteasome ([proteasome] =
20 μg μL−1). Different samples of lysate were incubated for
half an hour at 37 °C along with 9 μL of 26S assay buffer and 1
μL of a DMSO solution of compounds 15 or 17 at different
concentrations (0, 0.1, 1, 10, and 100 μM). Then, 1 μL of the
10 × ABP cocktail was added and the samples were incubated
for other 30 min. Finally, 5 μL of the 4× sample buffer to
denature and reduce proteins was added and the samples were
boiled at 100 °C for 5 min.
The samples were fixed in the different lanes of a SDS-PAGE
stacking gel and then were made to run by gel electrophoresis
on the running gel. Figure 4 shows the SDS-PAGE gel results
where in the lane 1, it is possible to see the different β subunits
of the proteasome, highlighted with specific fluorescent
markers that bind them selectively: in blue, Cy5-NC-001
linked to the β1 subunits, in green, BODIPY(FL)-LU-112 was
selective to the β2 ones, and in red, BODIPY(TMR)-NC-005-
VS linked to the β5 ones.
In lane 2, 3, 4, and 5, increasing concentrations of probe 15
(from 10 to 104 nM) are reported, whereas in lane 7, 8, 9, and
10, the same increasing concentration of probe 17 (from 10 to
104 nM) can be found. For a concentration of 1000 nM, both
probes show a very good competition in binding the
proteasome; in fact, in lanes 4 and 5 and 9 and 10 the colored
lines relative to the other marked inhibitors are not visible. In
lane 8, the red stripes relative to the β5 subunits disappeared,
suggesting a higher activity of the probe 17 for these subunits.
To detect the fluorescence of probes 15 and 17 while they
bind the proteasome, several different light sources were tried
to excite the fluorophores but unluckily they did not match the
excitation wavelength of our probes and no fluorescence were
registered. Some possible explanations can be considered. We
cannot state if these probes maintain their fluorescence during
the interaction with the proteasome; it is also possible that the
Figure 3. Optimized structure of the ground state of compound 6 (A) and its first excited state (B). Orbitals involved in the first excite state of 6
without (C, D) and with (E, F) protic interactions taken into account. All calculations are at the SMD(DCM)-(TD)-CAM-B3LYP/6-31G(d,p)//
(TD)-B3LYP/6-31G(d,p) level, and the structures correspond to energy minima.
Table 1. Absorption λmax (nm) and Fluorescence Quantum










DCM 8.9 0.44 384 490 0.07
MeOH 33 0.55 380 488 0.01
ethylene glycol 39 23.5 384 455 0.02
DMSO/H2O 55 3.30 384 450 0.01
aConcentration 2 × 10−5 M in all solvents.
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fluorophores maintain their optical properties but the
excitation was not efficient. Alternatively, the probes 15 and
17 were not strong enough from the fluorescence point of view
to be detected with the instruments employed. We cannot
exclude potential quenching or degradation (instability of the
boron complex) during the interaction with the proteasome.
■ CONCLUSIONS
In conclusion, this work has shown the possible and reliable
application of nitrile oxide chemistry in the biomedical field,
especially as starting materials for the synthesis of some
fluorescent probes. The chemistry of isoxazoles,21 dating to
many decades ago, in the field of imaging probes seems to be a
promising and valuable alternative to azides.22 Azides, in fact,
do suffer from the need of copper to perform correctly the
cycloaddition. The use of copper and metals in general is
detrimental in a biological environment, and the chemistry we
offer by replacing azides with nitrile oxides is cleaner and safer;
the construction of the boron complexes is simple, reliable, and
robust. The methodology can be applied by taking advantage
of the variety of structures having the aldehydes as starting
compounds, to prepare corresponding nitrile oxides. In light of
this, we have indeed demonstrated the possibility to expand
the application of 1,3-dipolar cycloaddition reactions to obtain
a group of easily derivatizable fluorescent probes. We were able
to obtain two novel boron fluorescent probes 15 and 17 that
enhance the range of reactions suitable for the coupling with
proteasome inhibitors. For this purpose, the optical properties
of these compounds were investigated and suggest the
potential for employment as fluorescent tags in imaging
techniques. The drop of fluorescence quantum yield values for
compound 6 with respect to 5 remains a problem whose
solution is not far from the synthetic route we have followed,
while maintaining the validity of the chemical strategy. The
moderate quantum yield values maintained in the DMSO/
H2O mixture confirm the suitability of these compounds in the
cellular environment. The ABPP assays performed did not give
Scheme 5. Coupling of Ethynyl-Probe 5 with Azido-Substituted Epoxomicin 14; Inset Shows the Possible Structure for the
Oxirane Fragment Located at the End of Compound 15
Scheme 6. Coupling of Oxime-Probe 6 with Norbornene-Substituted Epoxomicin 16
Figure 4. SDS-PAGE gel of compounds 15 and 17 (lanes 2, 3, 4, and
5, for increasing concentrations of probe 15; lanes 7, 8, 9, and 10 for
increasing concentrations of probe 17; lane 1, specific fluorescent
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us the ultimate answer about the behavior of compounds 15
and 17 in SDS-PAGE analyses. The coupling tests performed
showed good reactivity for the probes 15 and 17, even with
short peptide chains such as epoxomicin. Improvement of the
fluorescence properties of enaminoketone-based boron com-
plexes is needed and actively pursued. At present, the tuning of
the optical properties of the probes is a crucial point for
making these compounds competitive with commercial ABPP
probes. The stability of the boron complex within the lisate
environment is also a key point for its application in imaging
techniques.
Design, synthesis, and application: these aspects must be
synchronized and to do that, brand new isoxazole derivatives
are currently under preparation by functionalizing the anthryl
moiety with several aromatic rings bearing donor and acceptor
substituents by means of the Suzuki coupling; moreover,
selected heterocycles have been inserted too (Scheme 7).23
This revised and enlarged library of isoxazoles was already
verified to show unexpected intense fluorescent properties,
even stronger than the corresponding boron complexes.
Fluorescent studies are actively pursued to compare the
photochemical behavior of the uncomplexed and complexed
probe couples (see Scheme 7) to determine the real need of a
boron complex to display optical properties in this type of
compound. These findings will be communicated in a full
paper that is under preparation.
■ EXPERIMENTAL SECTION
General Methods and Materials. Melting points (mp)
are uncorrected. Elemental analyses were performed on a
FlashSmart elemental analyzer. 1H NMR and 13C NMR were
registered on Bruker AVANCE 300 spectrometers in
deuterated solvent solutions. The chemical shifts are expressed
in ppm, using tetramethylsilane as the internal reference. IR
spectra were registered using a FT-IR PerkinElmer RX-1
spectrometer dissolving the analyzed products in DCM (film).
Chromatographic columns were obtained using Kieselgel 60,
70−230 (Merck), with a BIOTAGE MPLC or BIOTAGE
Isolera One with KP-SIL columns; the elution solvents were
from cyclohexane/ethyl acetate, 9:1, to pure ethyl acetate.
UV−vis spectra were registered with a Jasco V-550 UV−vis
spectrophotometer; the fluorescence spectra were registered
with a PerkinElmer LS 55 luminescence spectrometer.
Anthracenenitrile oxide 9 was prepared from the corre-
sponding commercially available oxime according to the
known procedure.24,3 Solvents and other reagents were
purchased and used without any further purification.
Synthesis of 4-(Prop-2-yn-1-yloxy)benzaldehyde oxime
(10). A solution of 3.20 g (46.0 mmol) of hydroxylamine
hydrochloride in 20 mL of water was added to 4.83 g (30.1
mmol) of 4-(prop-2-ynyloxy) benzaldehyde (8) dissolved in
125 mL of ethanol. NaOH solution was added to adjust the
pH at 5, and the reaction was heated at 40 °C for 3 h. The
mixture was then refluxed for 20 min and kept under stirring
overnight. Ethanol was partially evaporated until the formation
of a white solid, and water was added afterward. The mixture
was extracted with diethyl ether, and the combined organic
phases were dried over MgSO4 and evaporated after filtration.
The product was recrystallized from cyclohexane/ethyl acetate,
obtaining a white solid of 10 in 87% yield (4.60 g). Mp: 68−70
°C from cyclohexane/ethyl acetate. FT-IR: νCN 1603 cm−1;
νOH 3262 cm
−1. 1H NMR (δ, DMSO): 3.59 (s, 1H, CC−
H); 4.83 (s, 2H, CH2); 7.01 (AA′BB′, 2H, arom.); 7.54
(AA′BB′, 2H, arom.); 8.08 (s, 1H, NC−H); 11.02 (s, 1H,
OH). 13C NMR (δ, DMSO): 55.4; 78.4; 79.0; 115.1; 126.3;
127.7; 147.5; 158.0. Elemental analysis: calculated for
C10H9NO2 (MW = 175.06): C, 68.56; H, 5.18; N, 8.08;
found: C, 68.55; H, 5.15; N, 8.09.
Synthesis of 4-((3-(Anthracen-9-yl)isoxazol-5-yl)-
methoxy)benzaldehyde Oxime (11). In a 250 mL round-
bottom flask, 2.27 g (10.4 mmol) of anthracenenitrile oxide
(9) was added dropwise to a solution of 1.89 g (10.8 mmol) of
4-(prop-2-ynyloxy) benzaldehyde oxime (10) in 125 mL of
anhydrous DCM. The reaction was kept in the dark and under
stirring at room temperature for 48 h. Then, the mixture was
diluted with DCM (100 mL) and the solution was washed with
brine (3 × 50 mL) and dried over anhydrous Na2SO4.
The solvent was evaporated and the crude residue was
purified by column chromatography, giving a yellowish solid of
11 in 66% yield (2.69 g). Mp: 128−131 °C from cyclohexane/
ethyl acetate. FT-IR: νCN 1598 cm−1; νOH 3265 cm−1. 1H
NMR (δ, DMSO): 5.54 (s, 2H, CH2); 7.04 (s, 1H, CC−H);
7.19 (AA′BB′, 2H, arom.); 7.58 (m, 6H, anthr.); 7.72 (m, 2H,
anthr.) 8.14 (s, 1H, NC−H); 8.20 (AA′BB′, 2H, arom.);
8.83 (s, 1H, anthr.); 11.07 (s, 1H, OH).
13C NMR (δ, DMSO): 18.5; 60.7; 107.7; 115.3; 122.5;
124.9; 125.7; 126.7; 127.0; 127.9; 128.6; 129.0; 129.9; 130.7;
147.5; 158.4; 160.3; 168.4. Elemental analysis: calculated for
C25H18N2O3 (MW = 394.13): C, 76.13; H, 4.60; N, 7.10;
found: C, 76.15; H, 4.63; N, 7.09.
Synthesis of 4-((4-Amino-4-(anthracen-9-yl)-2-oxobut-3-
en-1-yl)oxy)benzaldehyde Oxime (12). Compound 11 (1.80
mmol, 720 mg) was dissolved in 120 mL of a 9:1 acetonitrile/
water mixture in a three-necked round-bottom flask. The
solution was stirred under nitrogen for 15 min, and then 605
mg of molybdenum hexacarbonyl (2.30 mmol) was added.
The reaction was stirred at 70 °C for 4 h.
DCM was then added, and the mixture was washed with
brine (3 × 50 mL). The organic phase was dried over
anhydrous Na2SO4 and evaporated. The crude product was
purified on column chromatography, giving a beige-reddish
Scheme 7. Synthetic Strategy toward Newly Designed Fluorescent Probesa
aThe Spacer can be also deleted, leaving a fully conjugated system.
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solid of 12 in 68% yield (491 mg). Mp: 183−189 °C from
cyclohexane/ethyl acetate. FT-IR: νCN 1579 cm−1; νOH/NH2
3265 cm−1. 1H NMR (δ, DMSO): 4.66 (s, 2H, CH2); 5.40 (s,
1H, CC−H); 6.93 (AA′BB′, 2H, arom.); [7.11] (AA′BB′,
2H, arom.); 7.53 (AA′BB′, 2H, arom.); 7.53 (m, 4H, anthr.);
[7.85] (AA′BB′, 2H, arom.); 7.97 (m, 2H, anthr.); 8.07 (s, 1H,
NC−H); 8.13 (m, 2H, anthr.); 8.47 (s, 1H, NH2); 8.71 (s,
1H, ant.); 9.88 (s, 1H, OH); 10.25 (s, 1H, NH2); [10.95] (s,
1H, OH). 13C NMR (δ, DMSO): 70.8; 93.4; 93.5; 114.5;
114.8; 124.8; 125.2; 125.5; 126.2; 127.4; 127.5; 128.0; 129.5;
130.2; 130.7; 130.7; 131.3; 147.2; 158.5; 161.5; 161.7; 190.9;
191.2; 192.0. Elemental analysis: calculated for C25H20N2O3
(MW = 396.15): C, 75.74; H, 5.08; N, 7.07; found: C, 75.75;
H, 5.03; N, 7.08.
Synthesis of 4-((4-(Anthracen-9-yl)-2,2-difluoro-2,3-dihy-
dro-1λ3,3,2λ4-oxazaborinin-6-yl)methoxy)benzaldehyde
Oxime (6). Compound 12 (2.30 mmol, 916 mg) was dissolved
in 100 mL of anhydrous DCM along with 10 mL of distilled
triethylamine in a 250 mL three-necked bottom flask. The
solution was stirred under a nitrogen atmosphere for 10 min,
and then 4 mL of boron trifluoride etherate (32.4 mmol) was
added. The reaction was stirred under a nitrogen atmosphere
overnight. The mixture was then diluted with DCM (20 mL)
and washed with brine (3 × 50 mL). The organic phase was
dried over anhydrous Na2SO4 and evaporated, obtaining a dark
oil. The crude product was then purified on column
chromatography, giving a yellow solid of 6 in 40% yield (409
mg). Mp: 179−184 °C from from cyclohexane/ethyl acetate.
FT-IR: νNH 3362 cm
−1; νOH 3272 cm
−1; νCN 1614 cm−1. 1H
NMR (δ, DMSO): 5.05 (s, 2H, CH2); 6.06 (s, 1H, CC−H);
7.03 (AA′BB′, 2H, arom.); 7.51 (AA′BB′, 2H, arom.); 7.62
(m, 4H, anthr.); 7.62 (bs, 1H, NH); 7.71 (m, 2H, anthr.); 8.07
(s, 1H, NC−H); 8.23 (m, 2H, anthr.); 8.86 (s, 1H, anthr.);
11.03 (s, 1H, OH); [11.16] (s, 1H, OH). 13C NMR (δ,
DMSO): 30.7; 67.0; 97.6; 115.0; 123.8; 125.9; 126.5; 127.2;
127.7; 127.8; 128.8; 129.5; 130.4; 147.4; 158.1; 172.0; 175.2.
Elemental analysis: calculated for C25H19BF2N2O3 (MW =





(13). PIFA (20 mg) was dissolved in 50 mL of DMSO along
with boron complex 6 (123 mg). After 5 min, 150 mg of 2-
norbornene was added and the mixture was stirred for 4 h. The
mixture was then extracted with DCM, and the combined
organic phases was dried over Na2SO4. The solvent was
evaporated and the product was purified by a chromatographic
column, giving a yellow solid (13) in 81% yield (122 mg). Mp:
>210 °C from ethyl acetate. FT-IR: νCN 1598 cm−1; νNH
3361 cm−1. 1H NMR (δ, DMSO): 1.15 (d, 1H, norb.); 1.26
(d, 1H, norb.); 1.48 (m, 4H, norb.); 3.64 (d, J = 8, 1H, norb.);
4.55 (d, J = 8, 1H, norb.); 5.08 (s, 2H, CH2); 6.06 (s, 1H, C
C-H); 7.07 (AA′BB′, 2H, arom.); 7.63 (AA′BB′, 2H, arom.);
7.63 (m, 4H, anthr.); 7.73 (m, 2H, anthr.); 8.85 (s, 1H,
anthr.); 11.18 (s, 1H, NH). 13C NMR (δ, DMSO): 22.1; 26.6;
31.8; 56.2; 67.0; 86.7; 97.6; 115.1; 122.3; 123.8; 125.8; 125.9;
127.2; 127.6; 128.2; 128.8; 129.5; 130.4; 130.7; 137.1; 156.0;
158.4; 172.0; 175.1. Elemental analysis: calculated for
C32H27BF2N2O3 (MW = 536.21): C, 71.66; H, 5.07; N,







kynyl fluorescent probe 5 (2.71 mg, 6.37 μmol) was dissolved
in 1 mL of argon-degassed DMF along with 3.64 mg (6.26
μmol) of azido-epoxomicin 14. An aqueous solution of CuSO4
(1 mg, 4 μmol) and sodium ascorbate (1 mg, 5 μmol) was
added to the mixture, and the solution was then stirred
overnight at room temperature under an argon atmosphere.
The crude product was purified by silica gel column
chromatography (DCM/MeOH 9:1) to give 8.59 mg of
cycloadduct 15 (6.37 μmol).
The product weight was initially higher than expected
probably due to some water residue that was very difficult to
remove. After a series of careful drying processes, the product,
obtained in 55% yield, was submitted for relative character-
ization by mass spectrometry.
The mass spectrum (MS) reporting a mass value of 1023.30
m/z corresponds to the molecular weight of 15 (1006.94 m/z)








a solution of 1.59 mg (3.58 μmol) of oxime fluorescent probe
6 in argon-degassed DMF was added 1.74 mg (5.40 μmol) of
PIDA. The solution was stirred for 10 min under an argon
atmosphere, and then 1.98 mg (2.62 μmol) of norbornene-
epoxomicin 16 was added to the solution. The mixture was
stirred overnight at room temperature.
The crude product was purified by silica gel column
chromatography (DCM/MeOH 9:1) to give 1.87 mg (1.56
μmol) of cycloadduct 17 (45% yield).
Due the known reactivity of nitrile oxides and the nature of
the dipolarophile, the purification step was quite problematic
and several steps of chromatographic purification were needed.
The final cycloadduct 15 was obtained, and the MS spectrum
confirmed its structure with MW = 1199.30 (theor. 1199.15)
m/z.
Density Functional Theory (DFT) and Time-Depend-
ent DFT Calculations. Calculations were performed using
Gaussian 09, Revision E.01. All optimizations were performed
using the SMD(DCM)-(TD)-CAM-B3LYP/6-31G(d,p)//
(TD)-B3LYP/6-31G(d,p) level of theory (over the first 10
singlet states). The identity of the stationary points was




The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acsome-
ga.9b00672.
Synthesis of 4-(prop-2-yn-1-yloxy)benzaldehyde (8);
competitive ABPP assays (SDS-PAGE); UV−vis and
fluorescent spectra of compounds 6, 5, 15, and 17 in
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DCM, MeOH, ethylene glycol, and DMSO/H2O 1:1, as
well as the corresponding fluorescent spectra and the
quantum yield data; 1H and 13C spectra of all new
synthesized compounds; MS spectra of the final adducts
15 and 17 (PDF)
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